Belarus starts vaccination against coronavirus using vaccine by China’s Sinopharm started in on Mar 15
<p> MINSK, Mar 15 - PrimePress. Vaccination with the Chinese vaccine SARS-CoV-2 Vaccine (Vero Cell) Inactivated, manufactured by Sinopharm, began in Belarus on 15 March 2021, the press service of the Belarusian Ministry of Health said. </p> <p> </p> <p> “The medication has undergone the necessary laboratory control, during which experts of the Ministry of Health were convinced of its quality and safety. The first health facility where SARS-CoV-2 Vaccine (Vero Cell) was used was the outpatient clinic No. 36 in Minsk,” reads the report. </p> <p> </p> <p> According to Healthcare Minister Dmitry Pinevich, currently specialists are discussing the prospects of producing the vaccine in Belarus. It may happen on the basis of the China-Belarus Industrial Park Great Stone. </p> <p> </p> <p> As previously reported, in February 2021, China sent to Belarus 100 thousand doses of a coronavirus vaccine produced by Sinopharm on a free basis. This is the first vaccine approved by the State Pharmaceutical Administration of China to enter the market and is already actively used in the country. According to estimates by the Chinese side, the Sinopharm vaccine showed 79.34% efficacy in trials. End </p>
2021-03-16
Primepress
Belarus starts vaccination against coronavirus using vaccine by China’s Sinopharm started in on Mar 15
MINSK, Mar 15 - PrimePress. Vaccination with the Chinese vaccine SARS-CoV-2 Vaccine (Vero Cell) Inactivated, manufactured by Sinopharm, began in Belarus on 15 March 2021, the press service of the Belarusian Ministry of Health said.
“The medication has undergone the necessary laboratory control, during which experts of the Ministry of Health were convinced of its quality and safety. The first health facility where SARS-CoV-2 Vaccine (Vero Cell) was used was the outpatient clinic No. 36 in Minsk,” reads the report.
According to Healthcare Minister Dmitry Pinevich, currently specialists are discussing the prospects of producing the vaccine in Belarus. It may happen on the basis of the China-Belarus Industrial Park Great Stone.
As previously reported, in February 2021, China sent to Belarus 100 thousand doses of a coronavirus vaccine produced by Sinopharm on a free basis. This is the first vaccine approved by the State Pharmaceutical Administration of China to enter the market and is already actively used in the country. According to estimates by the Chinese side, the Sinopharm vaccine showed 79.34% efficacy in trials. End